Pfizer defends Bextra after new report on risks
479171
NEW YORK  - Pfizer dismissed a report on the safety of its pain reliever Bextra, but the new controversy weighed on the stock price of the US pharmaceutical giant.
507272
Pfizer Inc. said Friday that it will provide health-care professionals with additional information about its Bextra arthritis drug and that it will conduct further studies to confirm the drug&#39;s long-term cardiovascular safety record.
438179
Shares of Pfizer Inc. slipped on Wednesday, following reports that a study had likened the companyâs Bextra arthritis drug to Merck&#39;s Vioxx in terms of its cardiovascular risks.
443157
U.S. health officials Thursday called on doctors to limit prescribing Pfizer Inc. painkillers Celebrex and Bextra in light of recent evidence that they may increase the risk of heart attack and stroke.
665144
More evidence of how painkillers called COX-2 inhibitors can raise the risk of heart disease was published Monday, showing Pfizer Inc.'s Bextra can triple the risk of heart attack and stroke in certain patients.
582657
New reports suggest another drug company moved too slowly to pull a dangerous medication from the market and question the Food and Drug Administration&#39;s ability to protect the public.
633767
Drugmaker Pfizer Inc. is in talks with  regulators over a likely change to arthritis drug Bextra's  label to warn doctors about the risk of a potentially deadly  skin reaction, the company said in a regulatory filing.
141451
SINGAPORE : Doctors in the United States have warned that painkillers Bextra and Celebrex may be linked to major cardiovascular problems and should not be prescribed.
665827
It was enough to prompt Wall Street analyst Timothy Anderson to wonder: Does Bextra stand for &quot;Be Extra Careful?&quot;. The controversy over the safety of some widely sold arthritis pain medicines
443018
The US Food and Drug Administration yesterday ordered strengthened boxed labels for Pfizer&#39;s Bextra, warning of possible heart and blood clotting problems.
238122
The Food and Drug Administration yesterday called for an evaluation of all prevention studies involving two controversial painkillers - Celebrex and Bextra - to ensure adequate protection for participants who use the pills.
625109
Doctors writing in a prominent medical  journal on Friday recommended that physicians stop prescribing  Pfizer Inc.'s Bextra painkiller, just as a large study found  the drug maker's sister drug, Celebrex, doubled risk of heart  attacks.
745709
At a research and development meeting for analysts on Nov. 30, Pfizer (PFE ) stayed on message all day long. Despite questions about possible safety issues with arthritis pain medication Celebrex, patent challenges
742524
Pfizer Inc. and Canadian health officials moved Thursday to answer concerns over the painkiller Celebrex after a news report raised safety questions about the drug.
449178
US regulators warned yesterday of possible heart risks with Pfizer&#39;s Bextra, delivering another blow to popular pain drugs cox-2 inhibitors such as Vioxx, withdrawn from the market by Merck in September.
594114
Drugmaker Pfizer Inc. is in talks with  regulators over a likely change to arthritis drug Bextra's  label to carry a strict warning alerting doctors of the risk of  a potentially deadly skin reaction, the company said in a  regulatory filing.
457534
Pfizer Inc. may strengthen the warning label for its painkiller Bextra to account for more information about a rare but serious skin reaction.